Tuesday, July 17, 2007

Cdk5: the REAL Threat to the VIX

On the heels of Rob Schumacher's warning that the VIX may be waning, I have just this morning discovered an even bigger threat to the VIX that is brewing in MIT's Picower Institute for Learning and Memory.

In brief, biochemists at the Picower Institute claimed to have isolated the molecular basis for fear and have successfully treated that fear in mice. In an article in Nature Neuroscience, Li-Huei Tsai, Picower Professor of Neuroscience in the Department of Brain and Cognitive Sciences, summarizes the research team's findings as follows:

"In our study, we employ mice to show that extinction of learned fear depends on counteracting components of a molecular pathway involving the protein kinase Cdk5. We found that Cdk5 activity prevents extinction, at least in part by negatively affecting the activity of another key kinase."
If science can take the fear out of investing, whither the VIX?


DISCLAIMER: "VIX®" is a trademark of Chicago Board Options Exchange, Incorporated. Chicago Board Options Exchange, Incorporated is not affiliated with this website or this website's owner's or operators. CBOE assumes no responsibility for the accuracy or completeness or any other aspect of any content posted on this website by its operator or any third party. All content on this site is provided for informational and entertainment purposes only and is not intended as advice to buy or sell any securities. Stocks are difficult to trade; options are even harder. When it comes to VIX derivatives, don't fall into the trap of thinking that just because you can ride a horse, you can ride an alligator. Please do your own homework and accept full responsibility for any investment decisions you make. No content on this site can be used for commercial purposes without the prior written permission of the author. Copyright © 2007-2023 Bill Luby. All rights reserved.
Web Analytics